Simultaneous determination of paracetamol and chlorpheniramine in human plasma by liquid chromatography-tandem mass spectrometry

被引:77
作者
Celma, C [1 ]
Allué, JA [1 ]
Pruñonosa, J [1 ]
Peraire, C [1 ]
Obach, R [1 ]
机构
[1] Ipsen Pharma, Dept Metab & Pharmacokinet, St Feliu De Llobregat 08980, Barcelona, Spain
关键词
validation; paracetamol; chlorpheniramine;
D O I
10.1016/S0021-9673(99)01252-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An analytical method for the determination of paracetamol and chlorpheniramine in human plasma has been developed, validated and applied to the analysis of samples from a phase I clinical trial. The analytical method consists in the extraction of paracetamol and chlorpheniramine with diethyl ether, followed by the determination of both drugs by an LC-MS-MS method, using 2-acetamidophenol as internal standard. The intra-assay and inter-assay precision and accuracy of this technique were good and the limit of quantitation was 0.5 mu g/ml of plasma for paracetamol and 0.2 ng/ml for chlorpheniramine. The concentration working range was established between 0.5 mu g/ml and 25 mu g/ml for paracetamol and between 0.2 ng/ml and 50 ng/ml for chlorpheniramine. This method has been used for analyzing more than 1200 human plasma samples from a clinical study with 24 volunteers. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 16 条
[1]   Simultaneous determination of pyrimethamine and sulphadoxine in human plasma by high-performance liquid chromatography after automated liquid-solid extraction [J].
Astier, H ;
Renard, C ;
Cheminel, V ;
Soares, O ;
Mounier, C ;
Peyron, F ;
Chaulet, JF .
JOURNAL OF CHROMATOGRAPHY B, 1997, 698 (1-2) :217-223
[2]   SINGLE DOSE BIOAVAILABILITY OF ACETAMINOPHEN FOLLOWING ORAL-ADMINISTRATION [J].
BORIN, MT ;
AYRES, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 54 (03) :199-209
[3]   Rapid liquid chromatographic assay for the determination of acetaminophen in plasma after propacetamol administration:: application to pharmacokinetic studies [J].
Campanero, MA ;
Calahorra, B ;
García-Quétglas, E ;
López-Ocáriz, A ;
Honorato, J .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 20 (1-2) :327-334
[4]   ESTIMATION OF HEPATIC 1ST-PASS EFFECT OF ACETAMINOPHEN IN HUMANS AFTER ORAL-ADMINISTRATION [J].
CHIOU, WL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (10) :1734-1735
[5]  
CLARK R, 1973, LANCET, V1, P66
[6]   CLINICAL PHARMACOKINETICS OF PARACETAMOL [J].
FORREST, JAH ;
CLEMENTS, JA ;
PRESCOTT, LF .
CLINICAL PHARMACOKINETICS, 1982, 7 (02) :93-107
[7]   A VALIDATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF PARACETAMOL AND ITS MAJOR METABOLITES IN URINE [J].
GOICOECHEA, AG ;
DEALDA, MJL ;
VILAJATO, JL .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1995, 18 (16) :3257-3268
[8]   SUBNANOGRAM QUANTITATION OF CHLORPHENIRAMINE IN PLASMA BY A NEW RADIOIMMUNOASSAY AND COMPARISON WITH A LIQUID-CHROMATOGRAPHIC METHOD [J].
MIDHA, KK ;
RAUW, G ;
MCKAY, G ;
COOPER, JK ;
MCVITTIE, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (08) :1144-1147
[9]   HIGHLY SENSITIVE DETERMINATION OF CHLORPHENIRAMINE AS FLUORESCENCE DERIVATIVE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
MIYAMOTO, Y .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 420 (01) :63-72
[10]   GLC DETERMINATION OF CHLORPHENIRAMINE IN HUMAN-PLASMA USING A NITROGEN SENSITIVE THERMIONIC DETECTOR [J].
OBRIEN, JE ;
HINSVARK, O ;
BRYANT, W ;
AMSEL, L ;
LEADERS, FE .
ANALYTICAL LETTERS, 1977, 10 (14) :1163-1173